Depuy Hip Recall News



view:  full / summary

Does A Victim of Faulty Hip Replacement Stand Well-compensated?

Posted by [email protected] on October 25, 2012 at 6:25 PM Comments comments (0)

Before Johnson & Johnson subsidiary DePuy Orthopaedic was put into trial later this year, the company officials paid about $200,000 as settlement over two ASR hip implants lawsuits from Nevada, court records show. It has ordered avoluntarily recall over its hip replacement devices in 2010 and has been facingabout 8,000 lawsuits in which DePuy and Johnson & Johnson President Tommy Eiguren was already given subpoena.


What usually triggers a person to undergo hip replacement is when they suffer from osteoarthritis which is considered as the most common form of arthritis,affecting millions of people around the world. It is usually called wear-and-tear arthritis which occurs when the protective cartilage on the endsof a person bones wears down over time, according to website.


Despite several preventive measures that have been recommended, still osteoarthritis will get worse in time, and no cure exists. But osteoarthritis treatments may slow the progression of the disease, relieve pain andimprove joint function.


Meanwhile, the offer for a settlement transpired when Johnson  & Johnson faces more than 8,000 cases alleging the ASR hips are defective, according to courtfilings. U.S. District Judge David Katz in Toledo, Ohio, is overseeing about6,000 federal suits that have been consolidated for pretrial evidence gathering. The drug maker also is defending itself in more than 2,000 casesfiled in courts in California, Maryland, Nevada and other states.


The first settlements involved cases filed in state court in Las Vegas, the people familiar with the accords said. Claims by Annelise Rundle, Martha Bender andKatherine Guy had been consolidated and set for trial Dec. 3, according to court documents.


However,the settlement offer was considered by Eric Gordon, a business professor at the University of Michigan who follows the pharmaceutical industry, as the expected company settlement offer in which he estimated the range from $200,000 to $500,000 per case.



The DePuy hip recalled about 93,000 ASR hips worldwide in 2010, including 37,000 in the U.S., saying more than 12 percent of the devices failed within five years. Lawsuits in federaland state courts describe patients in pain and immobilized by joint dislocations, infections and bone fractures.